Delivery Order SPE2DB22D2006-SPE2DB25FW3FQ
- Not listed
- The Defense Logistics Agency awarded a $14,958.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 21, 2025. This non-set-aside contract was competitively awarded on July 18, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management within military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,083.70 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Dexcom G7 is a...
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.88 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a federal medical supply provider,...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.80 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order issued under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The order represents a child contract utilizing the broader SPE2DX vehicle, valued at approximately $1 billion and running through December 2026, which...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contract...
- The Defense Logistics Agency awarded a $2,062.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive set-aside delivery order under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under contract 4569029682, valued at $1,031.20 with a firm fixed price structure. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The Dexcom G7 is a continuous glucose monitoring system used for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used in diabetes management. This competitively awarded, non-set-aside contract has a ceiling value of $2,165.52 and firm fixed pricing, with an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3FQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The Dexcom G7 is a continuous glucose monitoring system used for diabetes management, aligning with the company's extensive portfolio of diabetes care products and medical devices supplied to federal healthcare systems. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the DLA Medical Supply Chain, AmerisourceBergen supplies pharmaceutical products, medical devices, and healthcare commodities to military and veteran healthcare systems globally. The company's federal procurement track record demonstrates consistent capability in fulfilling competitive federal medical supply requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/8/25 |